MMS
$68.39-0.34 (-0.49%)
Maximus, Inc.
Recent News
1 Value Stock on Our Watchlist and 2 We Ignore
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6?
Organon & Co. develops branded and biosimilar therapies with a focus on women’s health and specialty pharmaceuticals.
Xerox, ASGN, Maximus, CoStar, and Ryan Specialty Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after a combination of hot inflation data and geopolitical turmoil rattled investor confidence.
Reasons Why You Should Hold ABM Stock in Your Portfolio
ABM rides strong demand, acquisitions and shareholder returns, but rising costs and geopolitical pressures threaten margins and growth outlook.
2 Reasons to Like MMS (and 1 Not So Much)
Over the past six months, Maximus’s shares (currently trading at $72.42) have posted a disappointing 17.5% loss while the S&P 500 was flat. This was partly driven by its softer quarterly results and might have investors contemplating their next move.